There are no official ways to diagnose<unk>  in patients because it has not yet been recognized in any official diagnostic manual for psychiatry, such as the DSM-5. However, some methods have been developed in attempt to gauge the proposed mental disorder's prevalence.<unk>  Scale (MDS-16) In 2015, a 14-item self-report measurement known as the<unk>  Scale or MDS-16 was designed to identify abnormalities in the<unk>  of individuals. The purpose of designing this instrument was to provide a reliable and valid measurement of the existence of the proposed condition in patients, and to garner attention to the potential existence of<unk>  as a mental disorder. Later, an additional two items were added, assessing the use of music in fostering<unk> . The MDS-16 has been used in several countries such as the United States, Turkey, the United Kingdom, Italy, and Israel. Potential Comorbidity<unk>  has been identified to potentially have comorbidity with a number of already existing recognized mental disorder such as attention deficit hyperactivity disorder, anxiety disorder, major depressive disorder, and obsessive-compulsive disorder (OCD). In one case study, a patient believed to suffer from the condition was administered fluvoxamine, a medication typically used to treat those suffering from OCD. The patient found she was better able to control the frequency of her<unk>  episodes.
Maladaptive daydreaming
Schizoid avoidant behavior
Body-focused repetitive behavior
Musical anhedonia
Homicidal ideation
Automatic negative thoughts
Callous and unemotional traits
Hyperthymic temperament